The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Two significant programs that invested in research on diabetes, dementia, obesity and kidney disease have ended since the start of the Trump administration. By Gina Kolata Robert F. Kennedy Jr ...

(Courtesy/GettyImages) Millions of people around the world unknowingly live with a deadly trio: diabetes, high blood pressure and kidney disease. Often, they only realise the connection when it is ...

By identifying your risk factors for type 2 diabetes, you can take steps to avoid getting a disease that currently affects more than 34 million people in the United States. Insulin resistance occurs ...

Background Viral infections may trigger type 1 diabetes (T1D), and recent reports suggest an increased incidence of paediatric T1D and/or diabetic ketoacidosis (DKA) during the COVID-19 pandemic.

Dark leafy greens, fish, whole grains, low fat dairy products, and some carb sources may help manage diabetes and lower your risk of heart disease. Diabetes is a health condition in which the ...

The pill lowered the risk of cardiovascular-related death, heart attack and stroke by 14% compared to a placebo after four years on average in patients with diabetes and established heart disease ...

Novo Nordisk on Saturday said its diabetes pill Rybelsus showed cardiovascular benefits in a late-stage trial, paving the way for it to become a new treatment option for people living with ...

When it comes to the early detection of Alzheimer’s disease, a new study suggests that the nose knows. Mass General Brigham neurology researchers have created a smell test that shows promise as ...

for the STRIDE Trial Investigators. Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomized, ...

- Zimislecel (VX-880) pivotal trial on track to complete enrollment and dosing in H1 2025; Vertex expects to submit marketing applications to global regulators in 2026 - Vertex has completed ...